Prenatal testing: FDA rules will do more harm
Boston Globe Editorial The sequencing of the human genome a decade ago unleashed a deluge of information that seems unlikely to abate any time soon — and which some medical professionals need to do a...
View ArticleACLA Releases White Paper Detailing Legal Arguments Against FDA’s Proposal To...
WASHINGTON D.C. – The American Clinical Laboratory Association (ACLA) today released a white paper developed by recently retained expert legal counsel, former Solicitor General Paul D. Clement, a...
View ArticleACLA Oral Statement at FDA Workshop on Regulatory Framework for Laboratory...
BETHESDA, MD – Voicing its strong opposition to the Food and Drug Administration’s (FDA) draft guidance documents outlining that agency’s intent to regulate laboratory developed tests (LDTs), the...
View ArticleInside Health Policy: Clinical Lab Group Outlines Legal Arguments Against...
The American Clinical Laboratory Association, the group heading up efforts to quash FDA’s planned oversight of laboratory developed tests (LDTs), released a white paper Wednesday (Jan. 7) blasting...
View ArticleThe FDA’s Threat to the Practice of Medicine
In a new Roll Call opinion piece, attorneys Lawrence Tribe and Paul Clement outline the legal arguments against the Food and Drug Administration’s proposal to regulate laboratory developed tests. Click...
View ArticleACLA Lauds President’s Precision Medicine Initiative, Warns FDA Move to...
WASHINGTON, DC – The American Clinical Laboratory Association (ACLA) today commended the White House’s Precision Medicine Initiative intended to accelerate advances in disease treatment and cures, but...
View ArticleACLA in Comment Letter: FDA Lacks Statutory Authority in Ill-Advised Move to...
WASHINGTON, DC – The American Clinical Laboratory Association (ACLA) today submitted comments to the Food and Drug Administration (FDA) addressing FDA’s draft guidance to newly regulate laboratory...
View ArticleClik here to view.
Dark Daily: Obama’s $215 Million Precision Medicine Initiative: Will Congress...
Even as a new presidential initiative to boost precision medicine makes headlines, there is uncertainty as to how the program can be funded. The Precision Medicine Initiative was announced by President...
View ArticleACLA’s 20th Annual Conference Gathers Legal, Congressional & Regulatory...
WASHINGTON, DC – Scientists, physicians, researchers and lab clinicians will gather today in the nation’s capital to hear lawmakers, regulatory officials and legal experts address the most pressing...
View ArticleLaboratory Directors and Organizations Call on Congress to Enact Diagnostic...
Download (PDF, 209KB)
View ArticleStatement from the American Clinical Laboratory Association in Response to...
The Wall Street Journal story published today entitled Is Lab Testing the ‘Wild West of Medicine’ focuses on the Food and Drug Administration’s (FDA) move to regulate laboratory developed tests (LDTs)...
View ArticleStatement by the American Clinical Laboratory Association on the FDA Report...
(WASHINGTON, DC) – The American Clinical Laboratory Association (ACLA) provided an initial response today to a report issued by the Food and Drug Administration (FDA) on oversight of laboratory...
View ArticleLetter sent to Vice-President Biden on the Cancer Moonshot Task Force
Download (PDF, 241KB)
View ArticleACLA Underscores Value of Diagnostic Innovation in the Administration’s FY...
(Washington, D.C.) – In a letter to Vice President Joe Biden following the administration’s release of the FY 2017 budget including a proposed billion dollar funding of the Moonshot initiative aimed at...
View ArticleACLA Commends House Appropriations Committee for Including Language in...
WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) today applauded House Appropriations Committee Chairman Harold Rogers, R-KY and Subcommittee Chairman Robert B. Aderholt, R-AL,...
View ArticleACLA Comments to House Energy & Commerce Committee regarding draft...
Download (PDF, 370KB)
View ArticleACLA Applauds CMS Decision to Delay New Payment System, Evaluating Final PAMA...
(WASHINGTON, DC) –The American Clinical Laboratory Association (ACLA) – the nation’s largest organization representing the public policy interests of clinical laboratories — is reviewing the final rule...
View ArticleACLA Evaluating Draft FDA Guidance Documents, Calls on Administration to Work...
(WASHINGTON, DC) – The American Clinical Laboratory Association (ACLA) – the nation’s largest organization representing the public policy interests of clinical laboratories – called on the...
View ArticleACLA Letter to the Senate Committee on Health, Education, Labor and Pensions...
Download (PDF, 248KB)
View Article
